You are here: Industry Insights > dermatology

News List

Realm surrenders after back-to-back clinical defeats fiercebiotech
September 18, 2018
Faced with a pair of phase 2 failures, Realm Therapeutics has abandoned the platform that underlies all its drug development programs and engaged advisers to look into a possible sale...
Aurobindo to acquire dermatology and oral solids businesses from Sandoz financialexpress
September 07, 2018
The acquisition is in line with Aurobindo’s strategy to grow and diversify our business in the US
Zai Lab cans ex-GlaxoSmithKline eczema drug after phase 2 flop fiercebiotech
August 27, 2018
Zai Lab has stopped development of a treatment for atopic dermatitis after it failed to beat placebo in a phase 2a trial.
Almirall picks up Allergan's dermatology portfolio to for $650m pharmafile
August 06, 2018
Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 million in cash.
Almirall buys Allergan's US dermatology portfolio for $650 million pharmatimes
August 06, 2018
Spain’s Almirall has acquired Allergan’s US dermatology portfolio in a deal worth up to $650 million. This includes an upfront cash payment of $550 million and a potential earn-out of up to $100 million payable in 2022 based on the performance of the port
LEO Pharma to acquire Bayer’s prescription dermatology portfolio pharmaceutical-technology
August 03, 2018
Denmark-based LEO Pharma has signed a definitive agreement to acquire Bayer’s global prescription dermatology unit in a bid to expand its therapeutic areas and bolster a global footprint.
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report fiercepharma
May 08, 2018
As Novartis tries to shed some of its Sandoz offerings in the U.S. under intense pricing pressure, the drugmaker may have found a buyer for a generic dermatology business. India's Aurobindo has submitted a $1.6 billion offer for the unit, according to Liv
Science 37 and VisualDx Partner to Provide a More Patient-First Approach to Decentralized Clinical Research in Dermatology biospace
April 25, 2018
Science 37and VisualDxannounced today a strategic partnership that will empower the public to make better informed decisions with their doctors about managing skin problems.

Previous page 1 2 Next page